Literature DB >> 23911289

A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.

Katerina Hatzi1, Yanwen Jiang, Chuanxin Huang, Francine Garrett-Bakelman, Micah D Gearhart, Eugenia G Giannopoulou, Paul Zumbo, Kevin Kirouac, Srividya Bhaskara, Jose M Polo, Matthias Kormaksson, Alexander D MacKerell, Fengtian Xue, Christopher E Mason, Scott W Hiebert, Gilbert G Prive, Leandro Cerchietti, Vivian J Bardwell, Olivier Elemento, Ari Melnick.   

Abstract

The BCL6 transcriptional repressor is required for the development of germinal center (GC) B cells and diffuse large B cell lymphomas (DLBCLs). Although BCL6 can recruit multiple corepressors, its transcriptional repression mechanism of action in normal and malignant B cells is unknown. We find that in B cells, BCL6 mostly functions through two independent mechanisms that are collectively essential to GC formation and DLBCL, both mediated through its N-terminal BTB domain. These are (1) the formation of a unique ternary BCOR-SMRT complex at promoters, with each corepressor binding to symmetrical sites on BCL6 homodimers linked to specific epigenetic chromatin features, and (2) the "toggling" of active enhancers to a poised but not erased conformation through SMRT-dependent H3K27 deacetylation, which is mediated by HDAC3 and opposed by p300 histone acetyltransferase. Dynamic toggling of enhancers provides a basis for B cells to undergo rapid transcriptional and phenotypic changes in response to signaling or environmental cues.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911289      PMCID: PMC3854650          DOI: 10.1016/j.celrep.2013.06.016

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  41 in total

1.  Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

Authors:  Stella Maris Ranuncolo; Jose M Polo; Jamil Dierov; Michael Singer; Tracy Kuo; John Greally; Roland Green; Martin Carroll; Ari Melnick
Journal:  Nat Immunol       Date:  2007-06-10       Impact factor: 25.606

2.  CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells.

Authors:  Gersende Caron; Simon Le Gallou; Thierry Lamy; Karin Tarte; Thierry Fest
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

3.  BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.

Authors:  Leandro C Cerchietti; Katerina Hatzi; Eloisi Caldas-Lopes; Shao Ning Yang; Maria E Figueroa; Ryan D Morin; Martin Hirst; Lourdes Mendez; Rita Shaknovich; Philip A Cole; Kapil Bhalla; Randy D Gascoyne; Marco Marra; Gabriela Chiosis; Ari Melnick
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

4.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

5.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

Review 6.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

7.  The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis.

Authors:  Grant D Barish; Ruth T Yu; Malith S Karunasiri; Diana Becerra; Jason Kim; Tiffany W Tseng; Li-Jung Tai; Matthias Leblanc; Cody Diehl; Leandro Cerchietti; Yury I Miller; Joseph L Witztum; Ari M Melnick; Alexander L Dent; Rajendra K Tangirala; Ronald M Evans
Journal:  Cell Metab       Date:  2012-03-29       Impact factor: 27.287

8.  An integrated ChIP-seq analysis platform with customizable workflows.

Authors:  Eugenia G Giannopoulou; Olivier Elemento
Journal:  BMC Bioinformatics       Date:  2011-07-07       Impact factor: 3.307

9.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

10.  Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.

Authors:  Warren A Whyte; Steve Bilodeau; David A Orlando; Heather A Hoke; Garrett M Frampton; Charles T Foster; Shaun M Cowley; Richard A Young
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  88 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?

Authors:  Leandro Cerchietti; Ari Melnick
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

Review 3.  Germinal centres and B cell lymphomagenesis.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2015-03       Impact factor: 53.106

4.  BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress.

Authors:  Tharu M Fernando; Rossella Marullo; Benet Pera Gresely; Jude M Phillip; Shao Ning Yang; Geoffrey Lundell-Smith; Ingrid Torregroza; Haelee Ahn; Todd Evans; Balázs Győrffy; Gilbert G Privé; Masayuki Hirano; Ari M Melnick; Leandro Cerchietti
Journal:  Cancer Discov       Date:  2019-02-18       Impact factor: 39.397

5.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.

Authors:  Yanwen Jiang; Ana Ortega-Molina; Huimin Geng; Hsia-Yuan Ying; Katerina Hatzi; Sara Parsa; Dylan McNally; Ling Wang; Ashley S Doane; Xabier Agirre; Matt Teater; Cem Meydan; Zhuoning Li; David Poloway; Shenqiu Wang; Daisuke Ennishi; David W Scott; Kristy R Stengel; Janice E Kranz; Edward Holson; Sneh Sharma; James W Young; Chi-Shuen Chu; Robert G Roeder; Rita Shaknovich; Scott W Hiebert; Randy D Gascoyne; Wayne Tam; Olivier Elemento; Hans-Guido Wendel; Ari M Melnick
Journal:  Cancer Discov       Date:  2016-10-12       Impact factor: 39.397

6.  BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.

Authors:  Joanna K Lempiäinen; A B M Kaiser Manjur; Marjo Malinen; Kirsi Ketola; Einari A Niskanen; Jorma J Palvimo
Journal:  Oncogene       Date:  2020-01-10       Impact factor: 9.867

Review 7.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

8.  TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.

Authors:  Pilar M Dominguez; Hussein Ghamlouch; Wojciech Rosikiewicz; Parveen Kumar; Wendy Béguelin; Lorena Fontán; Martín A Rivas; Patrycja Pawlikowska; Marine Armand; Enguerran Mouly; Miguel Torres-Martin; Ashley S Doane; María T Calvo Fernandez; Matt Durant; Veronique Della-Valle; Matt Teater; Luisa Cimmino; Nathalie Droin; Saber Tadros; Samaneh Motanagh; Alan H Shih; Mark A Rubin; Wayne Tam; Iannis Aifantis; Ross L Levine; Olivier Elemento; Giorgio Inghirami; Michael R Green; Maria E Figueroa; Olivier A Bernard; Said Aoufouchi; Sheng Li; Rita Shaknovich; Ari M Melnick
Journal:  Cancer Discov       Date:  2018-10-01       Impact factor: 39.397

9.  The dangers of déjà vu: memory B cells as the cells of origin of ABC-DLBCLs.

Authors:  Leandro Venturutti; Ari M Melnick
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

Review 10.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.